1,201 results on '"Wilcox, Mark H."'
Search Results
2. European Practice for CDI Treatment
3. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile
4. Clostridioides difficile canonical L,D-transpeptidases catalyze a novel type of peptidoglycan cross-links and are not required for beta-lactam resistance
5. A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways
6. Redefining Clostridioides difficile infection antibiotic response and clinical outcomes
7. How to: Clostridioides difficile infection in children
8. A global perspective on improving patient care in uncomplicated urinary tract infection: expert consensus and practical guidance
9. Public health case for microbiome-sparing antibiotics and new opportunities for drug development.
10. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
11. Case Series: Efficacy of Polyclonal Intravenous Immunoglobulin for Refractory Clostridioides difficile Infection
12. Development and clinical validation of an automated cell cytotoxicity neutralization assay for detecting Clostridioides difficile toxins in clinically relevant stools samples
13. Global Landscape of Clostridioides Difficile Phylogeography, Antibiotic Susceptibility, and Toxin Polymorphisms by Post-Hoc Whole-Genome Sequencing from the MODIFY I/II Studies
14. Factors affecting reported Clostridioides difficile infection rates; the more you look the more you find, but should you believe what you see?
15. Bezlotoxumab for prevention of Clostridium difficile infection recurrence: Distinguishing relapse from reinfection with whole genome sequencing
16. Impact of testing on Clostridioides difficile infection in hospitals across Europe: a mathematical model
17. Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)
18. Patient and Strain Characteristics Associated With Clostridium difficile Transmission and Adverse Outcomes
19. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection
20. The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials
21. Multicenter Prevalence Study Comparing Molecular and Toxin Assays for Clostridioides difficile Surveillance, Switzerland
22. European Practice for CDI Treatment
23. Lower Urinary Tract Infections: Management, Outcomes and Risk Factors for Antibiotic Re-prescription in Primary Care
24. The potential of microbiome replacement therapies for Clostridium difficile infection
25. Can SARS-CoV-2 be transmitted via faeces?
26. Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials
27. Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe
28. Correlation between restriction endonuclease analysis and PCR ribotyping for the identification of Clostridioides (Clostridium) difficile clinical strains
29. Evaluating the impact of testing strategies for the detection of nosocomial COVID-19 in English hospitals through data-driven modeling
30. The Molecular Epidemiology of Clostridioides difficile Infection in Central India: A Prospective Observational Cohort Study
31. Molecular testing in suspected infectious diarrhoea—the value of negative results
32. Two Distinct Patterns of Clostridium difficile Diversity Across Europe Indicating Contrasting Routes of Spread
33. A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens : REVIVE-1
34. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children : 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
35. Clostridium difficile
36. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records
37. Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis
38. Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe
39. The effect of pulmonary surfactant on the in vitro activity of Iclaprim against common respiratory bacterial pathogens
40. Tracking COVID-19 via sewage
41. Is there a causal relationship between trehalose consumption and Clostridioides difficile infection?
42. Comparison of Control of Clostridium difficile Infection in Six English Hospitals Using Whole-Genome Sequencing
43. Contribution to Clostridium Difficile Transmission of Symptomatic Patients With Toxigenic Strains Who Are Fecal Toxin Negative
44. A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens
45. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
46. Effects of control interventions on Clostridium difficile infection in England: an observational study
47. Method comparison for the direct enumeration of bacterial species using a chemostat model of the human colon
48. 271 - Clostridial and Clostridioides Infections
49. Comparison of the 2010 and 2017 Infectious Diseases Society of America guidelines on the diagnosis and treatment of Clostridium difficile infection
50. Real-Life Evidence for Tedizolid Phosphate in the Treatment of Cellulitis and Wound Infections: A Case Series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.